相关实验视频
Updated: Jan 14, 2026

10:28
Body Composition and Metabolic Caging Analysis in High Fat Fed Mice
Published on: May 24, 2018
16.3K
患有肥胖相关代谢障碍的狗的血液,生化和激素概况
Adrián Carzoli1, Paula Pessina1, Victor Castillo2
1Unidad de Imagenología, Laboratorio de Análisis Clínicos y LEMA, Facultad de Veterinaria-UdelaR.
The Journal of veterinary medical science
|January 12, 2026
概括
狗肥胖相关代谢障碍 (ORMD) 与胰岛素耐药性和炎症状态有关. 受影响的狗中,甘油三和血压等关键指标升高,这表明需要修订诊断标志物.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 比较病理学比较病理学
- 内分泌学 在内分泌学.
背景情况:
- 狗肥胖相关代谢障碍 (ORMD) 与人类代谢综合征有共同的指标,但其全部影响尚不清楚.
- 已确定的指标包括肥胖,高血压,高血糖,高甘油和高胆固醇.
研究的目的:
- 评估犬类ORMD指标及其与其他临床参数的相关性.
- 为了确定关键ORMD标记的区分能力和截止值.
主要方法:
- 根据既定的标准,肥胖狗 (n=39) 被归类为ORMD阳性或阴性.
- 评估包括血压,血液学,生物化学,荷尔蒙测定和尿液分析.
主要成果:
- 有ORMD阳性的狗表现出高胰岛素血症,高血糖症和胰岛素抵抗升高 (HOMA-IR).
- 在ORMD阳性狗中,静脉血压和血清甘油三水平往往更高.
- 增加的白细胞,淋巴细胞,总蛋白质和血球蛋白数量表明免疫-炎症反应.
结论:
- 狗的ORMD与胰岛素耐药性和一种促炎性血液和蛋白质特征有关.
- 总胆固醇可能不是ORMD的可靠标记,需要重新评估.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
235
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
235
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
165
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
165
Overview of Lipid Metabolism
4.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.8K

